CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −27,830 | 0 | ||
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −16,225 | 0 | ||
| 2021-08-03 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,775 | 158,225 | ||
| 2021-07-13 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +3,295 | $26.49 | $87K | 235,845 |
| 2021-07-13 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −3,295 | $33.69 | $111K | 232,550 |
| 2021-07-13 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +40,000 | $26.49 | $1.1M | 272,550 |
| 2021-07-13 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −40,000 | $33.74 | $1.3M | 232,550 |
| 2021-07-13 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,295 | 56,225 | ||
| 2021-07-13 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −40,000 | 16,225 | ||
| 2021-07-12 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +36,705 | $26.49 | $972K | 269,255 |
| 2021-07-12 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −36,705 | $33.55 | $1.2M | 232,550 |
| 2021-07-12 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +13,295 | $26.49 | $352K | 245,845 |
| 2021-07-12 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −13,295 | $33.55 | $446K | 232,550 |
| 2021-07-12 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −36,705 | 72,815 | ||
| 2021-07-12 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −13,295 | 59,520 | ||
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +26,705 | $26.49 | $707K | 259,255 |
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −26,705 | $32.79 | $876K | 232,550 |
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +5,603 | $26.49 | $148K | 238,153 |
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −5,603 | $32.29 | $181K | 232,550 |
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +17,692 | $19.47 | $344K | 250,242 |
Page 25 of 35 · 689 trades